[Treatment of acute myeloblastic leukemia].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001215:Asparaginase / Q000627:therapeutic use; D001792:Blood Platelets; D001803:Blood Transfusion; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D012075:Remission, Spontaneous
D000970:Antineoplastic Agents; D003561:Cytarabine; D003520:Cyclophosphamide; D001215:Asparaginase; D003630:Daunorubicin
Traitement des leucémies aiguës myéloblastiques.